Stratview Research has published a new report on the Interventional Radiology Market, segmented by Product Type (MRI Systems, CT Scanners, Ultrasound Imaging Systems, Angiography Systems, Fluoroscopy Systems, Biopsy Devices, and Others), by Procedure Type (Angiography, Angioplasty, Biopsy, Embolization, Thrombolysis, Vertebroplasty, Nephrostomy, and Others), by Application Type (Cardiology, Oncology, Gastroenterology, Urology & Nephrology, Obstetrics, Gynecology, and Others), by End-Use Type (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market.

Market Highlights

Interventional Radiology Market size was estimated at USD 24.5 billion in 2021 and is likely to grow at a CAGR of 5.3% during the forecast period of 2022-2028 to reach USD 35.16 billion in 2028. The demand for interventional radiology technologies such as CT scans, MRIs, ultrasounds, and others is driven by the shifting consumer preference for minimally invasive procedures. Minimally invasive surgeries have grown in popularity as they are cost-effective and require a shorter hospital stay. These factors, combined with the rising occurrence of various chronic diseases, particularly among the elderly, are expected to boost the technology adoption significantly, thereby contributing to the growth of the market over the forecast period.

Segmentation –

This report studies the Interventional Radiology Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:

Based on the product type, the market is segmented as MRI systems, CT scanners, ultrasound imaging systems, angiography systems, fluoroscopy systems, biopsy devices, and others. CT scanners are expected to account for the lion's share of the market during the forecast period due to the increasing demand for surgical, medical, or radiation treatment planning, as CT scans combine a number of X-ray images captured from various angles around the body and processes them to build cross-sectional images or slices of blood vessels, tissues, and bones. Furthermore, technological advancements in the healthcare sector are expected to drive the market growth over the forecast period.

Based on the procedure type, the market is segmented as angiography, angioplasty, biopsy, embolization, thrombolysis, vertebroplasty, nephrostomy, and others. Angiography is expected to be the dominant procedure type in the market during the forecast period. The growth of the segment is driven by the increasing demand for minimally invasive procedures and the growing prevalence of cardiovascular diseases.  Angiography also provides real-time imaging for better treatment. This is further expected to drive the market growth during the forecast period.

Following are the key players in the Interventional Radiology Market:

  • Carestream Health
  • Esaote S.P.A.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens AG
  • Toshiba Medical Systems Corporation

To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/Request-Sample/424/interventional-radiology-market.html#form

About Stratview Research-

Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.

Connect with our team here–
https://www.stratviewresearch.com/contact

Or

Call us @:  +1-313-307-4176